Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (321-330 of 333) with videos related to

Pageof 34
Sort By:
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Cancer Cell|September 13, 2017
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer DevelopmentYannick Boege, Mohsen Malehmir, Marc E Healy, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Gut|August 3, 2018
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosisPavel Strnad, Stephan Buch, Karim Hamesch, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Lancet (London, England)|August 12, 2023
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort studyMiquel Serra-Burriel, Adrià Juanola, Feliu Serra-Burriel, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021Gong Feng, Giovanni Targher, Christopher D Byrne, et al.
Pageof 34

Showing results (321-330 of 333) with videos related to

Sort By:
Pageof 34
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Cancer Cell|September 13, 2017
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer DevelopmentYannick Boege, Mohsen Malehmir, Marc E Healy, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Gut|August 3, 2018
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosisPavel Strnad, Stephan Buch, Karim Hamesch, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Lancet (London, England)|August 12, 2023
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort studyMiquel Serra-Burriel, Adrià Juanola, Feliu Serra-Burriel, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021Gong Feng, Giovanni Targher, Christopher D Byrne, et al.
Pageof 34